Personalized Gastrointestinal Stimulation System for Optimized Digestive Health
Legal Citation
Summary of the Inventive Concept
A next-generation, adaptive gastrointestinal stimulation system that utilizes wearable, implantable, or ingestible devices to monitor and modulate gut activity, providing real-time optimization of gut motility, nutrient absorption, and overall digestive health.
Background and Problem Solved
The original patent disclosed implantable and non-invasive stimulators for gastrointestinal therapeutics, but these systems have limitations in terms of personalization, adaptability, and real-time feedback. The new inventive concept addresses these limitations by introducing a closed-loop system that integrates sensor data, machine learning, and advanced stimulation techniques to provide a more effective and personalized approach to gastrointestinal health.
Detailed Description of the Inventive Concept
The system consists of a wearable, implantable, or ingestible device that monitors GI tract activity, pH levels, and nutrient absorption in real-time. The device is connected to a stimulation module that provides personalized, adaptive stimulation to the GI tract through novel, high-frequency electromagnetic fields or other advanced stimulation techniques. The system utilizes machine learning algorithms to analyze sensor data and predict GI tract disorders, enabling proactive, personalized interventions. The system can be controlled and monitored remotely through a mobile device or cloud-based platform.
Novelty and Inventive Step
The new inventive concept introduces a paradigm shift in gastrointestinal stimulation by integrating advanced sensing, machine learning, and stimulation techniques to provide real-time, personalized optimization of digestive health. The closed-loop system and adaptive stimulation approach are novel and non-obvious compared to the original patent, which focused on implantable and non-invasive stimulators with limited adaptability and personalization.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include ingestible capsules with integrated sensors and stimulation modules, implantable devices with advanced sensing capabilities, or wearable devices with AI-powered analysis and feedback. The system could also be integrated with other health monitoring devices, such as fitness trackers or smartwatches, to provide a more comprehensive approach to health and wellness.
Potential Commercial Applications and Market
The personalized gastrointestinal stimulation system has significant commercial potential in the healthcare and wellness industries, with potential applications in treating gastrointestinal disorders, improving digestive health, and enhancing overall wellness. The system could be marketed to healthcare providers, pharmaceutical companies, and consumers seeking personalized health solutions.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering, specifically gastrointestinal neural stimulation and monitoring technologies, requiring advanced knowledge of electrical engineering, neuroscience, and medical device design
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer with graduate-level training in neural interfaces, electrical stimulation techniques, and medical device development, familiar with advanced sensing and stimulation technologies for physiological modulation
Obviousness Rationale
A PHOSITA would recognize that the PTD's adaptive, machine learning-driven GI stimulation system represents a predictable technological progression from the source patent's basic transcutaneous stimulation approach. The core stimulation methodology remains fundamentally similar, with the PTD introducing incremental improvements in sensing, personalization, and adaptive control that would be considered routine engineering optimization for a skilled practitioner in neural stimulation technologies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,783 |
|---|---|
| Title | Implantable and non-invasive stimulators for gastrointestinal therapeutics |
| Assignee(s) | The Regents of the University of California |